FDA Inspection 786813 — Siegfried Hameln GmbH
The FDA completed an inspection of Siegfried Hameln GmbH on Jun 14, 2012 in Hameln. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 14, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hameln (Germany)